Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00675610 · ClinicalTrials.gov registry record · Phase 3
Enhancing Communication and HIV Outcomes
A Phase 3 study of HIV Infections, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 3
- Development phase
- 186
- Enrollment target
- 3
- Study locations
NCT00675610: Completed Phase 3 study of HIV Infections, sponsored by Johns Hopkins University.
NCT00675610 is a Phase 3 study of HIV Infections that has completed, run by Johns Hopkins University. The registered enrollment target is 186 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (58% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00675610, a Phase 3 study of HIV Infections, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 186 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this research is to improve communication between the patients with HIV and their health care providers. The overall purpose of doing so is to reduce disparities in medication self-efficacy, adherence to therapy, and HIV viral load suppression. The investigators will conduct a randomized controlled trial to test the effectiveness of a combined provider and patient communication intervention conducted at two separate visits compared to usual care in improving the quality of patient-provider communication, patients' medication self-efficacy, patient adherence to therapy, and HIV RNA suppression.
Conditions Studied
Interventions
- BEHAVIORAL communication training
Study Locations (3)
Michigan
- Wayne State University - Detroit
New York
- Saint Lukes-Roosevelt - New York
Oregon
- Oregon Health Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2008-05 |
| Est. Completion | 2010-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00675610
The ClinicalTrials.gov registry entry for NCT00675610 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 186 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (58% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which communication training is the first listed.
NCT00675610 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Michigan, New York, Oregon.
Frequently Asked Questions
What is clinical trial NCT00675610 about?
NCT00675610 is a clinical study titled "Enhancing Communication and HIV Outcomes". The goal of this research is to improve communication between the patients with HIV and their health care providers. The overall purpose of doing so is to reduce disparities in medication self-efficacy, adherence to therapy, and HIV viral load suppression. The investigators will conduct a randomized...
What is the current status of trial NCT00675610?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 186 participants. The study started on 2008-05. Estimated completion is 2010-05.
What conditions does trial NCT00675610 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT00675610?
The interventions under investigation include: communication training (BEHAVIORAL).
Who is sponsoring clinical trial NCT00675610?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00675610 being conducted?
This trial has 3 study locations across Michigan, New York, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1
RECRUITING · Phase 3
-
Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention
RECRUITING · Phase 3
-
SmartSteps: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use Disorder
RECRUITING · Phase 3
-
Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults
ACTIVE NOT RECRUITING · Phase 3
-
A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF
ACTIVE NOT RECRUITING · Phase 3
-
The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE
ACTIVE NOT RECRUITING · Phase 3
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.